Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009049
Filing Date
2015-11-02
Accepted
2015-11-02 09:17:45
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20150930.htm 10-Q 1453442
2 EX-31.1 ttph-ex311_6.htm EX-31.1 15708
3 EX-31.2 ttph-ex312_7.htm EX-31.2 15747
4 EX-32.1 ttph-ex321_8.htm EX-32.1 5923
5 EX-32.2 ttph-ex322_9.htm EX-32.2 5929
  Complete submission text file 0001564590-15-009049.txt   4476854

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20150930.xml EX-101.INS 804250
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20150930.xsd EX-101.SCH 33969
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20150930_cal.xml EX-101.CAL 27503
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20150930_def.xml EX-101.DEF 94852
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20150930_lab.xml EX-101.LAB 281575
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20150930_pre.xml EX-101.PRE 200110
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 151189516
SIC: 2834 Pharmaceutical Preparations